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The Covid‑19 Pandemic and Lockdowns
In December 2019, China reported the emergence of a pneu-
monia of unknown cause in Wuhan [1]. By 7 January 2020, 
the etiology of the pneumonia was attributed to a virus of 
the coronavirus family, and later on the disease was named 
coronavirus disease (COVID-19) on 11 February 2020 by 
the WHO [2, 3]. The symptoms of COVID-19 appear after 
an average incubation period of 5.2 days [1]. The median 
period from the onset of the disease to death is 14 days 
(range 6 to 41) [3]. Transmission of the virus is human to 
human through direct contact, or air droplets from infected 
persons spread by coughing or sneezing. The infection drop-
lets can also contaminate surfaces, and the virus can remain 
infectious for several days in the environment, providing a 
reservoir for the infection [4]. The majority of infections 
go into remission without intervention, while approximately 
15% will require hospitalization, with approximately 5% of 
these requiring intensive care [3, 4]. Unmitigated spread of 
COVID-19 creates pressure on health systems, and diverts 
resources that could have otherwise been better utilized for 
other health conditions. Sub-Saharan Africa health systems 
are already strained and are characterized by poor health 
outcomes with high mortality rates linked to the triple bur-
den of disease (HIV, tuberculosis, and non-communicable 
diseases) and out of pocket healthcare.
In response to the epidemic China imposed restriction 
such as quarantine (lockdown) of the whole city of Wuhan. 
This model proved efficacious, resulting in some Sub-Saha-
ran Africa countries implementing the same. The lockdown 
measures are in no way aimed at ending the pandemic but 
seek to protect the health systems of countries from being 
overwhelmed by flood of infected and sick patients need-
ing medical care. However, the restrictions come with unin-
tended consequences, such as widening inequalities, mental 
health problems, and exacerbating poor medical outcomes 
that are not COVID-19-related. Of particular interest to 
this paper, The Joint United Nations Programme on HIV 
and AIDS (UNAIDS) and the World Health Organization 
(WHO) have announced that the number of AIDS-related 
deaths in Sub-Saharan Africa could double if access to 
healthcare for people living with HIV (PLWH) is interrupted 
during the COVID-19 pandemic. While interruption to the 
supply of ARV drugs would have by far the largest impact 
of any potential disruptions [5], suspension of HIV testing 
would also have significant population impact.
Current State of the HIV Epidemic 
in Sub‑Saharan Africa
Sub-Saharan Africa (SSA) is home to over one billion 
people, with a current growth rate of 2.3% [6]. By the end 
of 2020, it is estimated that the SSA region will have an 
approximate population of 1.1 billion and it will account 
for most of the world’s population growth in the coming 
decades, whilst other regions’ populations will be declining 
[6]. However, with this growing population, the region has 
persisted as the epicenter of the HIV epidemic [7]. There 
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are over 26 million PLWH in Sub-Saharan Africa [7, 8]. It 
was estimated that 1.7 million new HIV infections occurred 
globally during the year 2018, which translates to 5000 new 
infections per day. Overall, 61% of these new infections 
occurred in SSA [7]. Key populations and their sexual part-
ners contributed approximately 25% of the new infections in 
the Eastern and Southern regions of Africa, whilst contribut-
ing 64% of the new infections in the Western and Central 
African regions [8]. In the Eastern and Southern region of 
Africa, 85% of PLWH knew their status, whilst 67% of those 
were on treatment and 58% of those on treatment had viral 
suppression [8]. In the Western and Central African region, 
64% of PLWH knew their status, 79% were accessing treat-
ment, and 76% had viral suppression [8]. Approximately 
310,000 people died due to HIV/AIDS in 2018 in East and 
Southern Africa, whilst 280,000 died in West and Central 
Africa [8]. Given the HIV disease burden in SSA, it is criti-
cal that the region continues to implement control efforts, 
even in the context of the COVID-19 pandemic [9]. Inter-
ventions that reach and test people earlier and retest persons 
with ongoing HIV risk have benefits not only for reducing 
HIV morbidity and mortality, but in interrupting and pre-
venting HIV transmission [10–12].
The Case for Scaling Up Home‑Based HIV 
Testing Interventions
HIV testing remains the primary entry point to care and 
treatment services. UNAIDS is targeting viral suppression 
in at least 73% of PLWH by the end of 2020 in an effort to 
end AIDS by 2030 [13]. This goal can only be achieved if at 
least 90% of the HIV infected population is diagnosed and 
linked to care. Historically, community-based testing has 
targeted volunteers, who were mostly women, to get tested. 
Men and youth are not as forthcoming with regards to test-
ing, and are disproportionately contributing to testing gaps 
[14–16]. While interventions have been in place to improve 
testing rates among these priority populations, confinement 
due to natural disasters in the Unites States [17] and violence 
in Kenya [18, 19] have been shown to hinder uptake of HIV 
testing services. The current COVID-19 crisis is even more 
complicated, as there are multifaceted barriers to facility-
based HIV testing, including but not limited to a lack of 
access due to the closure of facilities, shortage of staff due 
to illness, and reluctance by individuals to attend clinics due 
to fear of being exposed to SARS-COV 2 at health facilities 
[20].
The lockdown measures are in no way a panacea to the pan-
demic [9], but are aimed at ameliorating shocks to the health 
systems of countries due to flood of infected and sick patients 
needing medical care. The restrictive measures are, therefore, 
intended to manage COVID 19 spread and the number of cases 
requiring treatment at any given time—referred to as flattening 
the curve—so as to not overstretch health systems. However, 
the restrictions come with unintended consequences in terms 
of HIV testing and care [21]. Healthcare workers are focused 
on COVID 19 treatment and care, while the general public 
are quarantined or scared to seek medical attention for other 
illnesses due to the threat of acquiring the virus. The restric-
tive measures and threat of disease have curtailed access to 
provider-initiated and community testing. SSA has to consider 
the scaling up of home based HIV testing [22].
The WHO has recommended HIV self-testing (HIVST) as 
an additional method to increase HIV testing rates. HIVST 
affords individuals privacy, convenience, and empowering 
options for care [14, 15]. HIVST offers a means to fast track 
pre-screening and triaging out of those who self-test negative. 
HIVST can close the testing gap, as it can increase testing 
coverage and frequency. This allows the health system to focus 
only on those who require further assistance with respect to 
counselling, confirmation testing, and ART initiation. HIVST 
has the added benefit of reducing the number of health center 
visits during the period of quarantine and social distancing, 
in order to curb viral transmission. The COVID-19 pandemic 
has already placed a strain on the health system, and expan-
sion of the HIVST approach will ease the strain and help to 
prevent overwhelming of facilities with HIV testing. Multi-
ple studies conducted in the Sub-Saharan Africa region have 
already revealed high acceptance across individuals of vari-
ous demographics [14, 23]. HIVST can be made available on 
online drug stores, so that those requiring these services can 
order and have them delivered and use them in the comfort 
of their homes. Population Services International has already 
reported success with HIVST in Kenya [22]. In Eswatini, there 
has been a growing demand for HIV testing services during 
the COVID-19 pandemic, as people are interested in knowing 
their underlying conditions [24]. Scaling up of a home-based 
option to HIV testing such as HIVST could prove beneficial 
and improve health outcomes with little strain to the health 
system.
The COVID-19 pandemic and associated restrictive meas-
ures to curb its spread have stifled HIV testing. This not only 
threatens attainment of the UNAIDS goal to end AIDS by 
2030, but may result in increased AIDS-related mortality. 
Scaling up of HIVST has the potential to improve awareness 
of HIV status and increase Sub-Saharan Africa population’s 
ability to address and control the HIV epidemic, and save lives.
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